In the pivotal trial, side effects over 6 months in patients on Advair 250/50 were similar to those on Flovent
or Serevent alone.
Evohaler Flixotide, Flovent
, Seretide and Serevent are trademarks of the GlaxoSmithKline group of companies.
Following a Canadian recall of certain lots of the asthma drugs Ventolin Diskus, Flovent
Diskus, and Serevent Diskus, the Food and Drug Administration issued a warning for U.
Table 1: World Market for Inhaled Drug Delivery Systems (2004): Percentage Share Breakdown of Sales by Major Brands- Flovent
, Serevent, Pulmicort, Atrovent, Ventolin, and Others (includes corresponding Graph/Chart) II-8 Industry Efforts II-8 Inefficient Use of Pulmonary Drug Delivery Systems II-9 MDIs II-9 Spacers II-9 Dry Powder Inhalers II-10 Issues Facing Various Inhalation Devices II-10 Jet Nebulizers II-10 MDIs II-10 DPIs II-10
These include the FloTHERM family of IC, PCB and systems thermal simulation solutions, FloEFD(TM) concurrent CAD-embedded CFD for 3D fluid flow and heat transfer analysis, FloVENT
for HVAC analysis, Flowmaster 1D thermo-fluid simulation, and the T3Ster, as well as TeraLED transient temperature measurement systems for semiconductor and LED applications, the Power Tester 1500A for power cycling and thermal testing and DynTIM thermal interface material tester.
Flixotide and Flovent
contain the active ingredient fluticasone propionate, a potent inhaled corticosteroid, and are indicated for the treatment of asthma.
Flomerics' second product, Flovent
, was released in early 1990.
The products at issue, in addition to Zantac and Advair, were Flonase and Serevent for allergies, Zofran for nausea, Imitrex for migraines, Ventolin and Flovent
for asthma, and the antibiotic Ceftin.
Founded in 1997, the company's expertise runs deep in three major industry categories: financial services, life sciences, and technology/media/telecommunications with clients such as Qualcomm, GlaxoSmithKline makers of Advair and Flovent
, State Street Bank, Unisys, Berlex and Novo Nordisk.
office, where he directed the global project team to maximize Glaxo's respiratory products, including Advair, Flovent
, Advair and Symbicort: Market-leading branded asthma inhalers, such as GlaxoSmithKline's Flovent
and Advair and AstraZeneca's Symbicort continue to lead prescribing among pulmonologists and receive the most favorable treatment by MCOs than competing brands, although support will fall dramatically when patents start to expire in 2015.
, an inhaled bronchial steroid, generated $648 million, a gain of 67% over the prior year.